(Q39571250)

13 September 2017

Globalisation of international health (English)

1 reference

13 September 2017

G Walt

1

1 reference

PubMed ID

9482320

13 September 2017

language of work or name

English

0 references

publication date

1 February 1998

1 reference

13 September 2017

4

1 reference

inferred from page(s)

published in

The Lancet

1 reference

13 September 2017

351

1 reference

13 September 2017

434-437

1 reference

13 September 2017

9100

1 reference

European perspectives on hyperkinetic disorder

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Focal cerebral dysfunction in developmental learning disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Comorbidity in ADHD: implications for research, practice, and DSM-V.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

More frequent diagnosis of attention deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Hyperactivity and conduct problems as risk factors for adolescent development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Toward a pathophysiology of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Basal ganglia volumes in children with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Quantitative Brain Magnetic Resonance Imaging in Attention-Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Brain metabolism in teenagers with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Attention deficit disorder: a review of the past 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Gender differences in ADHD: a meta-analysis and critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Executive functions and developmental psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

The ecological validity of laboratory and analogue assessment methods of ADHD symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

The diagnosis of childhood hyperactivity. A U.S.-U.K. cross-national study of DSM-III and ICD-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Comorbidity: a critical issue in attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Behavioral and cognitive subtypes of ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Attention deficit disorder with hyperactivity among paediatric outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Epidemiology of childhood disorders in a cross-cultural context.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Hyperkinetic disorders in seven-year-old children with perceptual, motor and attentional deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

The diagnosis and prevalence of hyperactivity in Chinese schoolboys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Ontario Child Health Study. II. Six-month prevalence of disorder and rates of service utilization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

A general population screen for attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

The prevalence of attention deficit disorders in a rural midwestern community sample of nine-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

A longitudinal analysis of selected risk factors for childhood psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

A possible pathophysiologic substrate of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Brain morphology in developmental dyslexia and attention deficit disorder/hyperactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Cerebral glucose metabolism in adults with hyperactivity of childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Case study: adverse response to clonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

Three-year multimodality treatment study of 100 hyperactive boys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2911450-7

7 January 2021

10.1016/S0140-6736(97)11450-7

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

9482320